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ABSTRACT: New additions to the bioorthogonal chem-
istrycompendiumcanadvancebiologicalresearch byenabl-
ing multiplexed analysis of biomolecules in complex sys-
tems. Here we introduce the quadricyclane ligation, a new
bioorthogonal reaction between the highly strained hydro-
carbon quadricyclane and Ni bis(dithiolene) reagents. This
reaction has a second-order rate constant of 0.25 M
 1 s
 1,
on par with fast bioorthogonal reactions of azides, and pro-
ceeds readily in aqueous environments. Ni bis(dithiolene)
probes selectively labeled quadricyclane-modiﬁed bovine
serum albumin, even in the presence of cell lysate. We have
demonstrated that the quadricyclane ligation is compatible
with, and orthogonal to, strain-promoted azide alkyne
cycloaddition and oxime ligation chemistries by performing
all three reactions in one pot on diﬀerentially functionalized
protein substrates. The quadricyclane ligation joins a small
but growing list of tools for the selective covalent modiﬁca-
tion of biomolecules.
B
ioorthogonal chemistry is an enabling tool for biological
research as well as a challenging frontier in synthetic metho-
dology.
1 Bioorthogonal reaction development requires attention
to functional group reactivity and selectivity, as in any metho-
dology eﬀort, but in addition one must consider issues of water
stability, biocompatibility, and reaction kinetics in physiological
settings. To invent reactions within the conﬁnes of such unusual
boundary conditions, chemists have been compelled to explore
manifolds of reactivity outside the mainstream of organic synth-
esis.Somenotablesuccessstorieshavecomefromadaptations of
classic azide chemistry, such as the Staudinger ligation
2 and click
chemistry (both Cu-catalyzed
3 and Cu-free versions
4). These
bioorthogonal reactions have made it possible to probe a
particular biomolecule labeled with an azide using complemen-
tary reagents in vitro, in cells, and in live organisms.
5 However,
multiplexed analysis of several biomolecules in a given system
requires parallel use of a collection of bioorthogonal reactions.
The toolkithasexpandedconsiderably inrecent years
1butisstill
dwarfed by the compendium of conventional synthetic transfor-
mations, underscoring the need for new contributions.
In an eﬀort to develop new bioorthogonal reactions that are
themselves orthogonal to the current cohort, we sought to exp-
loreunrepresentedreactivityspace.Thepublishedbioorthogonal
transformations represent four broad reaction types: 1,3-dipolar
cycloadditions,
6Diels Alder reactions,
7metal-catalyzed couplings,
3,8
and nucleophilic additions.
2,9 Outside of this space lies the [2 +
2 + 2] cycloaddition reaction, a popular choice for the rapid
assembly of functionalized ring systems.
10 In practice, such rea-
ctions typically are metal-catalyzed as a means to overcome
anotherwisesigniﬁcantentropicbarrier.However,thehighlystrai-
ned hydrocarbon quadricyclane directly undergoes [2 + 2 + 2]
cycloaddition with speciﬁc types of π systems (Figure 1A).
11
Quadricyclane possesses many qualities that render it a
promising bioorthogonal reagent. First, it is abiotic, and we
envisioned that quadricyclane’s all sp
3-hybridized carbon system
would be unreactive with native biomolecules.
12 Second, the
molecule is relatively small
13 and may therefore be amenable to
biosyntheticincorporationintobiomolecules.Butwhatintrigued
us most was quadricyclane’s reactivity proﬁle. Its ∼80 kcal/mol
of strain
14 promotes cycloaddition with diazodicarboxylates and
other electron-deﬁcient π systems under mild conditions.
11 By
contrast, quadricyclane does not react readily with simple alkenes,
alkynes, or even cyclooctynes. As well, previous work has shown
that the rates of these cycloaddition reactions are greatly enhanced
by the “on water” eﬀect.
15
To identify a bioorthogonal reaction partner for quadricy-
clane, we screened a variety of candidates for reactivity at room
temperatureinaqueousorpolaraproticsolvents[TableS1inthe
Supporting Information (SI)]. Diazodicarbonyl compounds
showed promising kinetics but were not suﬃciently stable in
water for biological applications.
16 α-Fluoroketones and ﬂuori-
nated alkenes and alkynes reacted with quadricyclane too slowly
forpracticalutility,andsomeofthesereagentswerepronetoside
Figure 1. (A) A generic [2 + 2 + 2] reaction between quadricyclane
and a π electrophile to yield a norbornene cycloaddition product. (B)
7-Acetoxyquadricyclane (1) reacts with bis(dithiobenzil)nickel(II) (2)
to form complex 3. Complex 3 undergoes photodegradation to 2 and
7-acetoxynorbornadiene(4)unlessdiethyldithiocarbamate(5)ispr esent.
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reactions. One reagent stood out as a promising lead: bis-
(dithiobenzil)nickel(II) (2), a Ni bis(dithiolene) complex that
reacted cleanly with 7-acetoxyquadricyclane (1) to yield adduct3
(Figure 1B). Our results were consistent with a 1986 report by
Sugimori and co-workers highlighting the rapid reactivity of
2 with quadricyclane.
17 However, transforming this ﬁnding into
a bioorthogonal reaction—a “quadricyclane ligation”—re-
quired that we address the central criteria of water stability,
biocompatibility, and reaction kinetics in physiological settings.
First, we assayed the stability of 1 inwater and in the presence
of biological nucleophiles. We prepared 1 by the photochemical
[2 + 2] reaction of 4 as reported previously
18 (Scheme S1 in the
SI). Compound 1 was found to be stable in phosphate-buﬀered
saline (PBS, pH 7.4), with no observed degradation after more
than 2 months at room temperature (Figure S1 in the SI). We
also found 1 to be unreactive with sugars, a variety of oxidants,
and free amino acids, most notably cysteine (Figure S2).
Furthermore, quadricyclane was stable in the presence of bovine
serum albumin (BSA) and cell culture media under conditions
emulating those necessary for metabolic labeling experiments.
The limited solubility of commercially acquired 2 in polar
solvents precluded a thorough stability study, but the compound
was found to be unreactive with a variety of nucleophiles in
dichloromethane.
We then turned our attentiontothe stability of norbornene 3,
the product formed by ligation of 1and 2(Figure 1B). There are
reports that quadricyclane’s adduct with 2 undergoes light-
inducedreversiontonorbornadiene(anisomerofquadricyclane)
and 2.
19 Accordingly, we exposed 3 to ambient light and
monitored the formation of 2 and 4 (Figure 1B). The half-life
of thereversionwas∼35 hinCDCl3(Figures S3andS4), which
would be problematic for many biological labeling applications.
We predicted that the photochemical reversion could be inhib-
ited by removal of Ni from the product.
20 After screening a
variety of metal chelators (Table S2), we found that diethyl-
dithiocarbamate (5; Figure 1B) entirely prevented the photo-
degradation of 3 (Figure 1B and Figure S5).
Withthesepromisingresults, wepursuedthesynthesisofaNi
bis(dithiolene) reagent that is both water-soluble and function-
alized with a probe to detect biomolecule labeling. Compound
15 bearing two sulfonate groups and two biotin moieties was
designed for this purpose (Scheme 1). We prepared 15 and a
model compound, bis(isopropyl amide) 14, from dithiol-2-one
ligand precursors.
21 Brieﬂy, alkyne 6 was combined with xantho-
gen disulﬁde 7 in the presence of the radical initiator 1,10-
azobis(cyclohexanecarbonitrile) to yield dithiocarbonate 8.
22
Treatment of 8 with fuming sulfuric acid installed a single
sulfonate group and also hydrolyzed the methyl ester, producing
9 in good yield. Standard amide bond-coupling conditions were
used to conjugate either isopropylamine or an amine-functionalized
biotin derivative to 9,a ﬀording 10 and 11, respectively. These
intermediates were then converted to anionic Ni bis(dithiolene)
species 12 and 13 in situ by treatment with tetramethylammonium
hydroxide and NiCl2. Immediate oxidation with 0.5 equiv of iodine
aﬀordedthedesiredneutralcomplexes14and15.
23Gratifyingly,we
found that 14 and 15 are soluble in PBS at concentrations up to 5
and 10 mM, respectively.
The solubilities of compounds 14 and 15 enabled us to assess
the reaction kinetics with quadricyclane in aqueous/organic
solvent mixtures as well as to probe in more detail the stability
of these Ni bis(dithiolene) complexes in the presence of biomo-
lecules. Complex 14 has a large NIR absorption band at 850 nm
that is not present in the adduct with quadricyclane, allowing for
pseudo-ﬁrst-order kinetic measurements byabsorption spectros-
copy. We found that the second-order rate constant for the
reaction of 14 and 1 in a 1:1 PBS/EtOH mixture
24 was 0.25 (
0.05M
 1s
 1atroomtemperature(FiguresS6andS7).Thisrate
constant is comparable to those for cyclooctyne azide cycload-
ditions currently used for biological labeling applica-
tions
25 and should allow for the use of mild reaction conditions.
The stability of 14 was also monitored using the NIR absorp-
tion band, which is dependent on both the oxidation state of the
complex (i.e., 14 vs 12) and the connectivity of the dithiolene
ligands.
26 The absorption at 850 nm remained essentially un-
altered when 14 was incubated in PBS for 20 h (Figure S8). As
well, exposure to amino acids had either no eﬀect or a minimal
eﬀect on the absorption intensity (Figure S9). A marked excep-
tion was cysteine, which caused an immediate decrease in the
intensity of the 850 nm absorption band and the concomitant
appearance of a new band at ∼900 nm (Figure S10). This
transformation is consistent with reduction of 14 to 12,
26b and
treatmentof14withotherreducingagentsyieldedsimilarresults
(Figure S11). The neutral complex could be regenerated by
addition of K3Fe(CN)6, as judged by the reappearance of the
absorption band at 850 nm and restoration of the reactivity with
1 (Figures S12 and S13). Concerned that 14 would undergo
redox reactions with free thiol groups of protein-associated
cysteine residues, we monitored the integrity of the Ni bis-
(dithiolene) complex in the presence of BSA, which possesses a
solvent-exposed cysteine side chain.
27 Incubation with BSA led
to reduction of 14 but at a lower rate than observed with free
cysteine (Figure S14). Therefore, protein-mediated reduction
should not undermine the much faster quadricyclane ligation.
Notably, 14 was stable toward oxidized insulin over a 5 h period
(Figure S15).
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The quadricyclane ligation was then subjected to the ﬁrst
criticaltestofbioorthogonality: selectiveprotein labeling. We
modiﬁedlysineresiduesonBSAwithquadricyclanep-nitrophenyl
carbonate 16 (Figure 2A).
28 We then treated either quadricyclane-
modiﬁed BSA (QC-BSA) or native BSA with 50 μM 15 for
variousamountsoftimeand,afterquenchingwithexcess5and1,
assayed the products by Western blot probing with an α-biotin
antibody conjugated to horseradish peroxidase (α-biotin HRP).
We were excited to see that 15 selectively labeled QC-BSA in
a time-dependent manner with very little background labeling
of unmodiﬁed BSA, even upon prolonged exposure of the
Western blot (Figure 2B). Similarly, when the reaction time was
held constant (30 min) and the concentration of 15 was varied,
dose-dependent labeling was observed, again with minimal non-
speciﬁc reactivity (Figure 2C). As well, pretreatment of QC-
BSA with tetrasulfonated Ni bis(dithiolene) 17
29 quenched the
protein-boundquadricyclanemoiety,asdemonstratedbyreduced
labeling with 15 (Figure 2D). To determine whether the quad-
ricyclaneligationpossessedtheheightened selectivityrequiredfor
labeling of target biomolecules within more complex samples, we
combined 1.5 μg of QC-BSA (or unmodiﬁed BSA) with 25 μgo f
E. coli lysate. This mixture was treated with 50 μM 15 for 30 min,
quenched as described above, and analyzed by Western blot.
Selective labeling of QC-BSA was observed, but the signal was
weak(FigureS16).Wehypothesizedthatthediminishedsignalwas
duetoreductionof15byaspeciespresentinthelysate.Gratifyingly,
whenweaddedK3Fe(CN)6(1mM)tothereactionmixture,robust
and selective labeling of QC-BSA was observed (Figure 2E).
Newadditionstothebioorthogonalreactioncompendiumare
most powerful when they can be used in conjunction with other
bioorthogonal chemistries. We therefore aimed to determine
whether the quadricyclane ligation can be performed simulta-
neouslywithtwoestablishedbioorthogonalreactions,Cu-freeclick
chemistry and oxime formation, which are already known to be
mutually compatible.
30 A mixture containing equal protein loads
of QC-BSA (MW ∼66 kDa), azidohomoalanine-containing
dihydrofolate reductase (Az-DHFR, MW ∼23 kDa),
31 and alde-
hyde-taggedmaltosebindingprotein(CHO-MBP,MW∼42kDa)
32
Figure 2. Ni bis(dithiolene) reagents selectively label quadricyclane-modiﬁed BSA. (A) Modiﬁcation of BSA’s solvent-exposed lysine residues with
compound 16 and subsequent labeling with biotinylated Ni bis(dithiolene) reagent 15. (B, C) Ni bis(dithiolene) 15 displays (B) time- and (C) dose-
dependent labeling of QC-BSA. BSA ( ) or QC-BSA (+) (5 μg) was treated with (B) 50 μM 15 for various amounts of time or (C) various
concentrations of 15 for 30 min. The reactions were quenched with 1 and 5, and the presence of product was detected by Western blot using α-biotin-
HRP. (D) Reaction of 15with QC-BSAcan beprevented by pretreatment with tetrasulfonated Nibis(dithiolene) 17. BSA( )or QC-BSA (+)(5 μg)
was treated with various amounts of 17 for 30 min followed by 50 μM 15 for 30 min. The reactions were quenched with 1 and 5, and the samples were
analyzedbyWestern blotprobingwithα-biotin-HRP.(E)QC-BSAcanbeselectivelylabeledinamixtureofproteins. To25μgoflysate inthepresence
of1mMK3Fe(CN)6wasaddednoBSAorreagent(lane1),BSA(1.5μg)and50μM15(lane2),andQC-BSA(1.5μg) and50μM15(lane3).After30min,
the reactions were quenched with 1and 5and analyzed by Western blot. The BSA monomer and dimer bands are visible in the QC-BSA-treated sample. The
bands denoted with asterisks represent a biotinylated E. coli protein. In (B E), equal protein loading was veriﬁed by Ponceau stain.
Figure 3. The quadricyclane ligation is orthogonal to Cu-free click
chemistryandtheoximeligation.(A)AmixtureofQC-BSA,Az-DHFR,
and CHO-MBP (8 μg each) was treated with 15 (150 μM), DIMAC-
ﬂuor(250μM),andH2NO-FLAG(1mM)for3hat37C,pH4.5.This
mixture was basiﬁed with 850 mM tris buﬀer and quenched with excess
1, 5, and 2-azidoethanol. (B) The mixture was separated into three por-
tions, and each portion was analyzed by Western blot probing with a
diﬀerent antibody: α-biotin-HRP (quadricyclane ligation), α-ﬂuores-
cein-HRP (Cu-free click chemistry), or α-FLAG-HRP (oxime ligation).
ThePonceaustainindicatesthatallthreeproteinswerepresent.Oligomer
bands were observed for BSA and DHFR.
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wastreatedwithnickelcomplex15,anazacyclooctyneconjugatedto
ﬂuorescein (DIMAC-ﬂuor),
33 and an aminooxy-functionalized
FLAG peptide (H2NO-FLAG)
32 (Figure 3A). After incubation
for 3 h, the mixture was separated into three portions, each of which
was analyzed by Western blot probing with one of the following
antibodies: α-biotin-HRP, α-ﬂuorescein-HRP, or α-FLAG-HRP
(Figure3B).As shown in Figure3B,eachlabeling reagent,including
15, reacted only with its complementary bioorthogonal partner.
34
Like the cyclooctyne and aminooxy probes, compound 15 showed
nosigniﬁcantlabelingofproteinslackingitspartner(quadricyclane),
nor did it interfere with the other bioorthogonal reactions.
In summary, the quadricyclane ligation is a promising bio-
orthogonalreactionthatcanbeusedforselectiveproteinlabeling
alongside other popular bioorthogonal chemistries. The two
reaction partners reliably form their covalent adduct in environs
as complex as cell lysates. The next challenge for this chemistry
willbeapplicationstocelllabeling.
35However,thequadricyclane
ligation in its present form is best suited for in vitro labeling
experiments; improvements will be important for its use in living
systems, where stabilizing additives such as K3Fe(CN)6 and diethyl-
dithiocarbamatearenotideal.
36Moredetailedstudiesintothebalance
of Ni bis(dithiolene) reactivity and redox stability are warranted, as
well as investigations of the adduct’s photochemistry. Nonetheless,
our results herein suggest that reactions of quadricyclane constitute a
fertile sector of reactivity space for bioorthogonal chemistry.
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